Fedele Lembo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fedele Lembo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aurelio Portincasa
Complex Unit of Plastic and Reconstructive Surgery, Department of Clinical and Experimental Medicine, Medical School, University of Foggia, 71100 Foggia, Italy
1 shared publication - Caterina Foti
Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‐J) University of Bari “Aldo Moro” Bari Italy
1 shared publication - Chiara Grillo
Infectious Diseases Unit, A.O.U. Policlinico Foggia, University of Foggia, 71122 Foggia, Italy
1 shared publication - Cristina Pizzulli
Unit of Pathology, Department of Clinical and Experimental Medicine, University of Foggia—University Hospital “Policlinico Riuniti”, Viale L. Pinto, 71122 Foggia, Italy
1 shared publication - Domenico Parisi
Reconstructive and Plastic Surgery Unit, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy
1 shared publication - Francesca Sanguedolce
Department of Pathology, University of Foggia, 71122 Foggia, Italy
1 shared publication
Latest Publications
- Open Access
- 12 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6447
Skin Cancers in People Living with Human Immunodeficiency Virus (HIV) Infection
Background/Objectives: The advent of combination antiretroviral therapy has led to significant reductions in HIV-related morbidity and mortality and, conversely, an increasing incidence of chronic diseases, such as cancer. This study aimed to assess the incidence of skin malignancies in a cohort of people living with HIV (PLWH) compared to HIV-uninfected individuals (HUPs). Methods: Between April 2023 and April 2025, PLWH attending the Infectious Disease Unit at Policlinico of Foggia, Italy, were invited for skin cancer screening (cases). During the same period, patients visiting the Dermatology Unit were asked to undergo skin cancer screening and a rapid HIV test. Those who tested negative were included as controls. Suspicious lesions were surgically excised at the Plastic Surgery University Unit and examined by a dermatopathologist. Results: We enrolled 91 cases and 91 controls. Precancerous and cancerous skin lesions were detected at similar rates in PLWH and HUPs (12% vs. 13.2% and 7.6% vs. 8.7%). The total number of cancerous and precancerous lesions was higher in the PLWH group. In both groups, basal cell carcinoma was the most common tumor. Squamous cell carcinoma, basosquamous carcinoma, and dermatofibrosarcoma protuberans were found only in PLWH. Conclusions: The higher risk of multiple and rare skin cancers in PLWH should be recognized by healthcare providers and patients. PLWH should have regular skin cancer screenings, especially if they have additional risk factors such as a history of extensive ultraviolet radiation exposure.
- 12 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6447
Open AccessSkin Cancers in People Living with Human Immunodeficiency Virus (HIV) Infection
Background/Objectives: The advent of combination antiretroviral therapy has led to significant reductions in HIV-related morbidity and mortality and, conversely, an increasing incidence of chronic diseases, such as cancer. This study aimed to assess the incidence of skin malignancies in a cohort of people living with HIV (PLWH) compared to HIV-uninfected individuals (HUPs). Methods: Between April 2023 and April 2025, PLWH attending the Infectious Disease Unit at Policlinico of Foggia, Italy, were invited for skin cancer screening (cases). During the same period, patients visiting the Dermatology Unit were asked to undergo skin cancer screening and a rapid HIV test. Those who tested negative were included as controls. Suspicious lesions were surgically excised at the Plastic Surgery University Unit and examined by a dermatopathologist. Results: We enrolled 91 cases and 91 controls. Precancerous and cancerous skin lesions were detected at similar rates in PLWH and HUPs (12% vs. 13.2% and 7.6% vs. 8.7%). The total number of cancerous and precancerous lesions was higher in the PLWH group. In both groups, basal cell carcinoma was the most common tumor. Squamous cell carcinoma, basosquamous carcinoma, and dermatofibrosarcoma protuberans were found only in PLWH. Conclusions: The higher risk of multiple and rare skin cancers in PLWH should be recognized by healthcare providers and patients. PLWH should have regular skin cancer screenings, especially if they have additional risk factors such as a history of extensive ultraviolet radiation exposure.